InMed Pharmaceuticals Inc banner

InMed Pharmaceuticals Inc
F:MWG0

Watchlist Manager
InMed Pharmaceuticals Inc Logo
InMed Pharmaceuticals Inc
F:MWG0
Watchlist
Price: 4.07 EUR -0.97% Market Closed
Market Cap: €36.3m

Wall St Price Targets

MWG0 Price Targets Summary
InMed Pharmaceuticals Inc

There are no price targets for MWG0.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
InMed Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
-35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 3 years is -35%.

Gross Profit
Forecast

N/A
Past Growth
-24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 3 years is -24%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MWG0's stock price target?
Not Available

MWG0 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for InMed Pharmaceuticals Inc?
Projected CAGR
-35%

The compound annual growth rate for Revenue over the next 3 years is -35%.

What is the Gross Profit forecast for InMed Pharmaceuticals Inc?
Projected CAGR
-24%

The compound annual growth rate for Gross Profit over the next 3 years is -24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett